DIAMOND BAR, Calif.--(BUSINESS WIRE)--Patients in the European Union (EU) with arrhythmias, also known as irregular heart rhythms, may now benefit from treatment with a new state-of-the art catheter, designed to reduce char and thrombus formation during ablation and give physicians improved range of motion during procedures to eliminate abnormal heart rhythms.
